Abstract
219O Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have